Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sanara MedTech (SMTI) Operating Leases (2019 - 2025)

Historic Operating Leases for Sanara MedTech (SMTI) over the last 7 years, with Q3 2025 value amounting to $2.3 million.

  • Sanara MedTech's Operating Leases rose 2470.75% to $2.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $2.3 million, marking a year-over-year increase of 2470.75%. This contributed to the annual value of $1.2 million for FY2024, which is 2880.06% down from last year.
  • As of Q3 2025, Sanara MedTech's Operating Leases stood at $2.3 million, which was up 2470.75% from $1.2 million recorded in Q2 2025.
  • In the past 5 years, Sanara MedTech's Operating Leases registered a high of $2.3 million during Q3 2025, and its lowest value of $222151.0 during Q4 2021.
  • Its 5-year average for Operating Leases is $1.2 million, with a median of $1.2 million in 2024.
  • In the last 5 years, Sanara MedTech's Operating Leases crashed by 3756.24% in 2021 and then soared by 56581.44% in 2023.
  • Over the past 5 years, Sanara MedTech's Operating Leases (Quarter) stood at $222151.0 in 2021, then skyrocketed by 127.45% to $505291.0 in 2022, then skyrocketed by 243.85% to $1.7 million in 2023, then fell by 28.8% to $1.2 million in 2024, then skyrocketed by 86.13% to $2.3 million in 2025.
  • Its last three reported values are $2.3 million in Q3 2025, $1.2 million for Q2 2025, and $1.3 million during Q1 2025.